Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Owlet
OWLT
Owlet
Regulation And Tariffs Will Hinder Digital Health Yet Spur Recovery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
16 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$11.00
32.8% undervalued
intrinsic discount
16 Aug
US$7.39
Loading
1Y
60.3%
7D
1.1%
Author's Valuation
US$11.0
32.8% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$11.0
32.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-99m
277m
2019
2021
2023
2025
2027
2028
Revenue US$276.9m
Earnings US$34.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
20.48%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.83%
Calculation
US$34.39m
Earnings '28
x
15.02x
PE Ratio '28
=
US$516.46m
Market Cap '28
US$516.46m
Market Cap '28
/
37.45m
No. shares '28
=
US$13.79
Share Price '28
US$13.79
Share Price '28
Discounted to 2025 @ 7.83% p.a.
=
US$11.00
Fair Value '25
